{"Symbol": "AERI", "AssetType": "Common Stock", "Name": "Aerie Pharmaceuticals, Inc", "Description": "Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, dry eye, retinal diseases, and other eye diseases. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma and ocular hypertension. The company is also developing AVX-012, a clinical-stage dry eye product candidate; and AR-1105 and AR-13503 sustained-release implants for treating retinal diseases. Aerie Pharmaceuticals, Inc. has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Drug ManufacturersSpecialty & Generic", "Address": "4301 Emperor Boulevard, Durham, NC, United States, 27703", "FullTimeEmployees": "380", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "500494944", "EBITDA": "-199219008", "PERatio": "None", "PEGRatio": "0", "BookValue": "1.931", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-5.169", "RevenuePerShareTTM": "1.786", "ProfitMargin": "-2.4736", "OperatingMarginTTM": "-2.2036", "ReturnOnAssetsTTM": "-0.3628", "ReturnOnEquityTTM": "-1.6434", "RevenueTTM": "81575000", "GrossProfitTTM": "42288000", "DilutedEPSTTM": "-4.418", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.139", "AnalystTargetPrice": "29.25", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "6.2209", "PriceToBookRatio": "5.754", "EVToRevenue": "6.0047", "EVToEBITDA": "0", "Beta": "0.9352", "52WeekHigh": "26.26", "52WeekLow": "10.22", "50DayMovingAverage": "12.3889", "200DayMovingAverage": "14.4633", "SharesOutstanding": "46514400", "SharesFloat": "45496694", "SharesShort": "8998241", "SharesShortPriorMonth": "9220130", "ShortRatio": "10.88", "ShortPercentOutstanding": "0.17", "ShortPercentFloat": "0.2369", "PercentInsiders": "2.08", "PercentInstitutions": "131.454", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}